This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Universität Zu Lübeck. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: The Innovations of Georg Sczakiel
Introduction
Georg Sczakiel is a notable inventor based in Groß Grönau, Germany. He has made significant contributions to the field of medicine, particularly in the development of antisense drugs. With a total of 3 patents to his name, Sczakiel's work focuses on innovative solutions for treating inflammatory diseases.
Latest Patents
One of his latest patents is an antisense drug aimed at the human intercellular adhesion molecule 1 (ICAM-1). This invention also includes antisense drugs specifically designed for canines, targeting ICAM-1 to treat inflammation of the buccal cavity. The invention involves an isolated antisense oligonucleotide that can be used to prevent or treat inflammatory diseases in canine subjects. Additionally, it encompasses compositions or articles of manufacture that include this antisense oligonucleotide.
Career Highlights
Georg Sczakiel is affiliated with the University of Lübeck, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on veterinary medicine and the treatment of inflammatory conditions.
Collaborations
Some of his notable coworkers include Rosel Kretschmer-Kazemi Far and Franziska Preuss, who have contributed to his research endeavors.
Conclusion
Georg Sczakiel's innovative work in the field of antisense drugs highlights his commitment to advancing medical treatments for both humans and animals. His contributions are paving the way for new therapeutic approaches in the treatment of inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile